QUORIT Logo
Explore Solutions

Guided by Science. Clinical Intellect.

ADVANCED WOUND CARE

Advanced Wound Care.
Guided by Science.

Quorit brings together clinical understanding, biomaterial science and research-driven innovation to develop wound-care solutions for diverse clinical needs.

"Because every wound is different. Effective care begins with understanding it."

CLINICAL METHODOLOGY SEQUENCE
UNDERSTAND · ASSESS · IDENTIFY · SELECT · EVIDENCE
Bioactive structural matrix and cellular healing scaffold
Bioactive Scaffold Dynamics
EXTRACELLULAR MATRIX REGULATION FIG. 03-A

Native triple-helix architectures supporting microvascular perfusion, fibroblast migration, and cellular homeostasis.

THE QUORIT APPROACH

From Understanding the Wound to Informed Wound Management

01 PHASE I

UNDERSTAND

Understand the wound and its clinical context thoroughly.

ETIOLOGY & HOST
02 PHASE II

ASSESS

Systematically assess the wound bed, tissue, and exudate.

T.I.M.E. PROTOCOL
03 PHASE III

IDENTIFY

Identify physiological and microbial barriers to healing.

BIOFILM & PROTEASE
04 PHASE IV

SELECT

Select an appropriate targeted wound-care approach.

BIOACTIVE SOLUTIONS
05 PHASE V

REVIEW

Review empirical clinical evidence and progress metrics.

DATA-BACKED TRIALS
ABOUT QUORIT

Advanced Wound Care.
Guided by Science.

Biomaterial synthesis, clinical trials, and tissue matrix scaffolding
"Understanding comes first."

The foundational premise governing our biomaterial synthesis, clinical trials, and bedside implementation.

Quorit is an advanced wound-care brand dedicated to the science of wound healing. We combine clinical understanding, biomaterial science and research-driven innovation to develop wound-care solutions for diverse clinical needs. Our approach begins with understanding the wound and the factors that may influence its progression, followed by the selection of appropriate solutions across the healing journey.

From biomimetic-based technologies to advanced wound dressings and supportive wound-care solutions, Quorit brings together a comprehensive portfolio designed around the evolving requirements of modern wound management.

Because every wound is different. Effective care begins with understanding it.

clinical_notes

CLINICAL UNDERSTANDING

Rooted in patient biology and systemic etiology.

biotech

BIO MATERIAL SCIENCE

Engineered biomimetic extracellular scaffolds.

science

RESEARCH-DRIVEN INNOVATION

Validating regenerative pathways empirically.

SCIENTIFIC FOUNDATION
1. Wilkinson HN, Hardman MJ. Wound healing: cellular mechanisms and pathological outcomes. Open Biol. 2020.
2. Frykberg RG, Banks J. Challenges in the treatment of chronic wounds. Adv Wound Care. 2015;4(9):560-582.
3. Wilkinson HN, Hardman MJ. Wound healing: cellular mechanisms and pathological outcomes. Open Biol. 2020.
BEFORE YOU TREAT THE WOUND

Ask What Is Driving It.

A wound cannot be understood by appearance alone. Start by understanding the cause, the patient and the wound itself.

CARD 01 help_center

CAUSE / ETIOLOGY

Underlying pathology determines biological progression and treatment constraints.

  • Diabetic Neuro-ischemic
  • Venous Insufficiency
  • Arterial Occlusive
  • Pressure / Shear Injury
  • Traumatic & Surgical Wounds
  • Other Atypical Ulcerations
DIAGNOSTIC FACTOR: ORIGIN
CARD 02 person_check

PATIENT FACTORS

Systemic physiology dictates cellular repair capacity and immune resilience.

  • Vascular Perfusion & ABI
  • Diabetes & Glycemic Control
  • Nutritional Albumin / Protein
  • Mobility & Mechanical Offloading
  • Immunosuppression & Comorbidities
DIAGNOSTIC FACTOR: HOST
CARD 03 vital_signs

WOUND FACTORS

Immediate microenvironmental conditions impeding or fostering re-epithelialization.

  • Anatomical Location & Depth
  • Surface Area & Chronicity
  • Pain Score & Quality
  • Exudate Viscosity & Volume
  • Peri-Wound Maceration / Erythema
DIAGNOSTIC FACTOR: LOCAL BED
BARRIER PATHWAY ANALYSIS

Why Do Some Wounds Fail to Progress?

In a healthy body, a wound follows a well-orchestrated path to healing. But sometimes, this journey is disrupted. Several biological and clinical factors can create barriers, keeping the wound trapped in a cycle of non-healing.

TRAUMA INITIATION A WOUND HAPPENS arrow_forward
BARRIER 01

EXCESS PROTEASE ACTIVITY

Persistent degradation of extracellular matrix & growth factors.

BARRIER 02

BIOFILM & MICROBIAL PERSISTENCE

Protected microbial communities resisting host defenses.

BARRIER 03

PERSISTENT INFLAMMATION

Chronic pro-inflammatory state trapping tissue repair.

BARRIER 04

IMPAIRED PERFUSION & HYPOXIA

Suboptimal microvascular delivery and oxygenation.

BARRIER 05

SYSTEMIC & LOCAL FACTORS

Metabolic dysregulation, pressure, and nutritional deficit.

CLINICAL STAGNATION HEALING DELAYED warning
ASSESSMENT METHODOLOGY

TIME: A Systematic Approach to Wound Assessment

How Do We Know What Is Holding the Wound Back? A systematic wound assessment helps turn a complex wound into identifiable clinical problems.

BED ASSESSMENT

"What Is in the Wound Bed?"

CORE CLINICAL QUESTION

Is the wound bed ready to heal?

LOOK FOR:

Necrotic Tissue Black / brown eschar
Fibrinous Slough Yellow / adherent mass
Deficient Tissue Pale, poor granulation

Clinical Purpose: Remove physical barriers, devitalized matrix, and bacterial niches to create a viable, vascularized wound bed capable of cellular adhesion.

Different types of debridement (autolytic, sharp, enzymatic, or mechanical) are selected to restore a viable wound environment.
STRATIGRAPHIC BED MODEL SPEC 10.1
layers Viable Tissue Restoration

Non-viable slough and fibrinous eschar clearance allows native granulation tissue and microvascular buds to colonize.

TARGET: HEALTHY RED GRANULATION DEBRIDEMENT PROTOCOL
FROM ASSESSMENT TO ACTION

What Did We Find?

Translating discrete clinical assessment parameters into an iterative therapeutic workflow.

TIME Parameter Identified Clinical Finding Therapeutic Objective Quorit Intervention Focus
T — Tissue Non-viable / deficient tissue, slough, or necrotic matrix Debridement, clearance, and healthy granulation bed creation Bioactive Scaffolds / Autolytic Dressings
I — Infection / Inflammation Persistent inflammation / recalcitrant microbial burden / biofilm Biofilm disruption, microbial reduction, protease attenuation Antimicrobial & Anti-inflammatory Matrices
M — Moisture Too dry / too wet / uncontrolled corrosive exudate Moisture balance, peri-wound protection, exudate absorption QuoroFoam® & QuoroPad® Exudate Systems
E — Edge Non-advancing / undermined / hyperkeratotic wound margins Epithelial advancement, contact guidance, wound contracture QuoroSkin® Native Structural Scaffolds
1

ASSESS

Systematic examination using TIME and systemic diagnostic indicators.

2

IDENTIFY

Isolate active barriers: bioburden, protease excess, or desiccation.

3

ADDRESS

Deploy tailored biomaterials, scaffolds, and protective dressings.

4

REASSESS

Continuously measure epithelial migration rate and tissue quality.

THERAPEUTIC ARMENTARIUM

Solutions Designed Around Wound-Management Needs

Following systematic assessment, Quorit brings together advanced wound-care solutions designed around the evolving requirements of modern wound management.

Explore Quorit Solutions Portfolio arrow_forward
Bioactive Wound Care Gel
Quorit wound care

Bioactive Wound Care Gel®

An optimised microenvironment for stalled or complex wounds. The biological scaffold ac…

INDICATED FOR - Chronic wounds - Trauma wounds - Surgical wounds - Infected wounds PRODUCT DETAILS CATEGORY: Advanced Dressing FORMAT: Topical Gel PRODUCT CODE Product…

QUOROGEL FORTE
Quorit wound care

QUOROGEL FORTE®

Bovine Collagen Gel with Nano-silver & Vitamin C A high-potency dual-layered structural…

INDICATED FOR - Complex wounds - High-exudate - Stagnant wounds - Post-surgical PRODUCT DETAILS CATEGORY: Primary Dressing FORMAT: Topical Gel PRODUCT CODE Product Cod…

QUOROSKIN
Quorit wound care

QUOROSKIN®

Pre-hydrated Advanced Dermal Matrix A pre-hydrated wet-collagen sheet delivering immedi…

Indicated For - 1st–2nd Burns - Donor sites - Abrasion - Graft sites Product Details CATEGORY: Silicon contact layer Product Codes and Sizes Product Codes Sizes Qc10…

QUOROSKIN-D
Quorit wound care

QUOROSKIN-D®

Biomimetic Dermal Matrix A high-affinity biological matrix that closely mimics the nat…

Indicated For - Skin grafts - 1st–2nd Burns - Superficial chronic wounds Product Details CATEGORY: Bioengineered Sheet Product Codes and Sizes Product Codes Sizes QC…

QUOROFIBER
Quorit wound care

QUOROFIBER®

FIBER MATRICES Advanced Wound Healing Fibrous Particles A high-performance bioactive…

Indicated For - Tunnelled wounds - Draining wounds - Open surgical wounds - Undetermined wounds Product Details CATEGORY: Bioactive Fiber STERILE: Yes Product Codes P…

QUOROFIBER-AB
Quorit wound care

QUOROFIBER-AB®

Anti-microbial Wound Healing Fibrous Particles A dual-action antimicrobial fiber matrix…

Indicated For - Infected wounds - Tunnelled wounds - Malodorous wounds - Open wounds Product Details CATEGORY: Antimicrobial Fiber STERILE: Yes Product Code Product C…

QUOROFOAM
Quorit wound care

QUOROFOAM®

FOAM DRESSINGS High-performance Absorbent Foam Dressing Rapidly draws excess fluid awa…

Indicated For - Heavy exudate - Moderate exudate - Surface wounds - Cavity wounds Product Details CATEGORY: Foam Dressing Product Codes and Sizes Product Code Size Qc…

QUOROFOAM-AG
Quorit wound care

QUOROFOAM-AG®

Silver Foam with Soft Silicone Adhesive Border Integrates a sustained-release ionic sil…

Indicated For - Infected wounds - Moderate–heavy exudate - Pressure injuries - Full-thickness wounds Product Details CATEGORY: Antimicrobial Foam Product Code and Size…

EMPIRICAL METHODOLOGY

Evidence That Informs Clinical Practice

Rigorous, peer-reviewed evaluation of biomaterial scaffolds across standardized preclinical and clinical study cohorts. Conservative data integrity without unsupported extrapolation.

Explore Clinical Evidence library_books
CASE DOSSIER PEER-REVIEWED

Recalcitrant Venous Ulcer Trajectory

Evaluation of bioactive matrix application in wounds unresponsive to conventional standard of care over a multi-week observation cycle.

Outcome Observed: Sustained reduction in excessive exudate volume and re-establishment of centripetal edge advancement.
Read Study Synopsis arrow_forward
BENCH RESEARCH IN VITRO ANALYSIS

MMP Sequestration & Hydrogel Affinity

Quantitative enzymatic assay measuring competitive sacrificial binding of active MMP-2 and MMP-9 against intact structural extracellular matrix.

Outcome Observed: Statistically significant moderation of proteolytic destruction of extracellular matrix proteins.
View Laboratory Protocol arrow_forward
SAFETY PROFILE BIOCOMPATIBILITY

ISO 10993 Biocompatibility Matrix

Comprehensive biological evaluation assessing cytotoxicity, sensitization, and intracutaneous reactivity across all Quorit dermal polymers.

Compliance: Zero hemolytic reaction or adverse irritation profiles noted across continuous dermal contact testing.
Examine Regulatory Dossier arrow_forward
CLINICAL CERTAINTY

Every Wound Is Different.
Understanding Comes First.

Explore the science, assessment framework and wound-care solutions behind Quorit. Connect with our medical affairs division for clinical evaluations.